Clinical Trial Update: Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the efficacy of a generic plerixafor in autologous hematopoietic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Plerixafor (generic) (plerixafor)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Lymphoma, Myeloma | Phase 1 | Status: COMPLETED